Recruiting at 2 sites No phase Clinical High Risk for Psychosis (CHR)

Prevention trial for Clinical High Risk for Psychosis (CHR)

Official title Developing a Recovery-Oriented Suicide Prevention Program for Young People at Clinical High Risk for Psychosis

ClinicalTrials.gov ID: NCT07756567

What this study is testing

What it's testing
The study will create and test a recovery‑focused suicide‑prevention group to see if it improves personal recovery and helps participants remember and use safety strategies.
Who it's for
Young people who are at clinical high risk for psychosis and have thoughts of suicide.
What's involved
Participants will join a group led by a clinician and a peer with lived experience, attend sessions on hope, goals, social connections, and suicide‑prevention skills, and may take part in a caregiver session; they will also give feedback on the program.
  • Which group you join is decided by chance.

A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.

Who can take part

Ages 12 to 30

You may be able to join if

  • Young Person
  • symptoms of clinical high risk for psychosis in the last two years
  • lifetime active suicide ideation and/or lifetime suicide behavior
  • not able to read and write in English Caregiver
  • has a familial relationship with the young person participant

You likely can't join if

  • employed at the University of California, San Diego or University of California, Los Angeles early psychosis program Administrator/Clinician...
See the full eligibility criteria
Who can join
  • Young Person
  • symptoms of clinical high risk for psychosis in the last two years
  • lifetime active suicide ideation and/or lifetime suicide behavior
  • not able to read and write in English Caregiver
  • has a familial relationship with the young person participant
  • has at least 4 hours of face-to-face contact with the patient participant every week, even if they do not live together Caregiver
What rules you out
  • employed at the University of California, San Diego or University of California, Los Angeles early psychosis program Administrator/Clinician Exclusion Criteria: None

The study team makes the final eligibility decision.

Where it is enrolling

  • Los Angeles, California, United States
  • San Diego, California, United States

Questions & answers

Do participants get paid in this trial?

This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.

Is it free to join, and do I need insurance?

Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part, but confirm specifics with the study team.

How long does this study last?

The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.

Who can join this trial?

This study is enrolling all sexes, 12 years to 30 years. The study team makes the final eligibility decision.

Where is this trial taking place?

This study is enrolling now at Los Angeles, California, United States; San Diego, California, United States. Enter your location above to see the nearest enrolling site and check your eligibility.

Explore other conditions

BridgeMD is an information and trial-matching tool that is independent of the study sponsor. Details come from ClinicalTrials.gov. The study team decides eligibility, and your own doctor gives medical advice.